Evidence map›Paper›PMID 35562995›Full record

ReviewInternational journal of molecular sciences2022

Cortactin in Lung Cell Function and Disease.

Mounica Bandela, Patrick Belvitch, Joe G N Garcia, Steven M Dudek

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mounica BandelaDepartment of Biomedical Engineering, College of Engineering, University of Illinois at Chicago, Chicago, IL 60607, USA.ORCID 0000-0002-7839-0948
Patrick BelvitchDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Joe G N GarciaDepartment of Medicine, University of Arizona, Tucson, AZ 85721, USA.ORCID 0000-0002-6934-0420
Steven M DudekDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0001-5624-0714
University of Illinois Chicago · USUniversity of Arizona · US

Funding

Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI Joe G. N. Garcia · 2016 to 2026
$24.4M
Group V Phospholipase A2 Mediates Acute Lung InjuryR01HL133059 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M · 2017 to 2020
$1.6M
Protein Regulation and Cytoskeletal Dynamics of Pulmonary Endothelial Barrier FunctionK08HL135318 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BELVITCH, PATRICK · 2017 to 2021
$975k
NHLBI NIH HHS K08 HL135318NHLBI NIH HHS P01 HL126609NIH HHS K08 HL135318NIH HHS P01 HL126609NIH HHS R01 HL133059
6 · The paper itself

Abstract

Cortactin (CTTN) is an actin-binding and cytoskeletal protein that is found in abundance in the cell cortex and other peripheral structures of most cell types. It was initially described as a target for Src-mediated phosphorylation at several tyrosine sites within CTTN, and post-translational modifications at these tyrosine sites are a primary regulator of its function. CTTN participates in multiple cellular functions that require cytoskeletal rearrangement, including lamellipodia formation, cell migration, invasion, and various other processes dependent upon the cell type involved. The role of CTTN in vascular endothelial cells is particularly important for promoting barrier integrity and inhibiting vascular permeability and tissue edema. To mediate its functional effects, CTTN undergoes multiple post-translational modifications and interacts with numerous other proteins to alter cytoskeletal structures and signaling mechanisms. In the present review, we briefly describe CTTN structure, post-translational modifications, and protein binding partners and then focus on its role in regulating cellular processes and well-established functional mechanisms, primarily in vascular endothelial cells and disease models. We then provide insights into how CTTN function affects the pathophysiology of multiple lung disorders, including acute lung injury syndromes, COPD, and asthma.

Indexed as

CortactinEndothelial CellsCytoskeletonLungPhosphorylationTyrosineCortactinTyrosineactin cytoskeletonARDSasthmaCOPDcortactinendothelium

Identifiers

PMID35562995
PMCPMC9101201
OpenAlexW4224305217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.